Kura Oncology Inc. KURA shares are up during Friday’s premarket session as the company reported promising data regarding its ...

Data from subset analysis of cabozantinib-pretreated patients support potential to overcome resistance and resensitize tumors to VEGF TKI ...

Darlifarnib is an investigational next-generation farnesyl transferase inhibitor designed to interfere with cellular pathways ...

Naomi Haas, MD, from the Hospital at the University of Pennsylvania, explains that most trials regarding neoadjuvant therapy ...

Kura Oncology (KURA) added ~5% in the premarket on Friday after releasing positive data from a Phase 1 trial for its next-gen farnesyl transferase inhibitor, darlifarnib (KO-2806), in patients with ...

In this segment on advanced renal cell carcinoma, Dr. McGregor focuses on how clinicians move beyond guideline ...

A cancer-causing chemical that is widely used to degrease aviation components and heavy machinery could also be linked to Parkinson's disease, according to a new research paper that recommends ...

Hereditary leiomyomatosis and renal-cell cancer (HLRCC) is an inherited disorder characterized by germline pathogenic variants in the gene encoding fumarate hydratase and an increased risk of ...

HOW TO TAKE THE POST-TEST: To obtain CME credit, please click here after reading the article to take the post-test on myCME.com. Nephrologists routinely use biopsy of the kidney for making diagnoses ...

Circulating tumor HPV DNA levels were linked to clinical risk in patients having surgery for HPV-related oropharyngeal cancer.